-
The prevalence of synthetic drugs is undercutting a previously effective and widely embraced treatment tactic. Now, the model pioneered in Vermont a decade ago and adopted nationwide is being forced to evolve.
-
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.
-
The government has proposed that Medicare fully cover PrEP, a change that could help America catch up with nations in Europe and Africa that are on track to end new infections decades before the U.S.
-
Many widely prescribed drugs and over-the-counter medications work differently in people who are obese, but exactly how and at what dose often isn't clear.
-
The CDC’s RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
-
Joe Biden's pick for the post next goes to a floor vote, but not before committee Chair Bernie Sanders tried to tie it to reducing the cost of prescription drugs.
-
The FDA had been expected to decide by next week, but a back-and-forth between state and federal officials about details of the proposal means the wait will continue, a court document says.
-
A Tampa-area mom couldn't watch her 9-year-old's leukemia go untreated. She started campaigning to fix a broken system and get patients the treatments they need in the face of drug shortages.
-
The point isn’t that Donald Trump managed drug shortages badly as president or that Joe Biden is handling them badly now, experts said. Many factors contribute to the problem.
-
A federal audit found lax oversight and multiple cases of child welfare workers failing to follow state regulations on psychotropic or opioid medication.